Hema Bhimnathwala

Hema Bhimnathwala is an accomplished professional with extensive experience in global auditing and compliance within the pharmaceutical industry. Currently serving as Associate Director at Organon since May 2021, Hema previously held various specialist roles at Merck, including Senior Specialist in CMC Document Auditing and Quality Management Systems Operations. Prior experience includes leadership in Trial Master File services at ICON plc and conducting audits for clinical and preclinical studies at Merck. Hema's career began with research roles at Osiris Therapeutics and earlier positions focused on cancer treatment and clinical research. Hema holds multiple degrees, including an M.S. in Pharmaceutical QA/RA from Temple University and an MS in Biotechnology from The Johns Hopkins University.